Assessment of clinical utility and predictive potential of pre-chemotherapy soluble urokinase plasminogen activator receptor: Observational single center study

Alteration of urokinase plasminogen activator receptor (uPAR) in neoplasms is a pre-requisite for invasiveness and metastatic ability. In the present study, we aimed to evaluate the relationship of pre-chemotherapy soluble uPAR (suPAR) with the odds for metastasis, lack of disease control, and its p...

Descripción completa

Detalles Bibliográficos
Autores principales: Beleva, Elina, Stoencheva, Snezhana, Deneva, Tanya, Nenova, Ivanka, Grudeva-Popova, Zhanet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Association of Basic Medical Sciences of Federation of Bosnia and Herzegovina 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113945/
https://www.ncbi.nlm.nih.gov/pubmed/36124441
http://dx.doi.org/10.17305/bjbms.2022.7857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10113945/
https://www.ncbi.nlm.nih.gov/pubmed/36124441
http://dx.doi.org/10.17305/bjbms.2022.7857

Ejemplares similares